NDA

NDA. A new drug application, as defined in the United States Federal Food, Drug and Cosmetics Act and the regulations promulgated thereunder, where such application is for a Licensed Product

NDA. Defined in the License Agreement

NDA. A New Drug Application or application for approval to market submitted to the FDA

NDA. Shall mean the Mutual Non-Disclosure Agreement, dated July 29, 2013, entered into by and among Cytori, and Bimini, and attached hereto as Exhibit D.

NDA. A New Drug Application submitted to the FDA

NDA. A New Drug Application submitted to the FDA in the United States for the PRODUCT.

NDA. The new drug application for a Product as required by the FDA, as amended or supplemented from time to time

NDA. A New Drug Application, Biologies License Application, Worldwide Marketing Application, Marketing Authorization Application, filing pursuant to Section 510(k) of the United States Federal Food, Drug, and Cosmetic Act, or similar application or submission for Marketing Authorization of a Licensed Product filed with a Regulatory Authority to obtain marketing approval for a biological pharmaceutical or diagnostic product in that country or in that group of countries.

NDA. A New Drug Application, filed with the FDA.

NDA. A New Drug Application filed with the FDA pursuant to and under 21 U.S.C. § 355(b) of the Act, together with the FDA's implementing rules and regulations